September 22, 2020

SAN RAMON, Calif., September 22, 2020—Over the past four months, CooperVision’s Essential Hospital Workers Complimentary Contact Lens Program enabled eye care professionals to provide support to patients working on the front lines of the COVID-19 pandemic. By the program’s conclusion on August 31, nearly 570 optometry practices from 46 states and the District of Columbia had chosen to extend the complimentary lenses to their patients.

“During these critical months of the pandemic, the Essential Hospital Workers Complimentary Contact Lens Program gave practitioners the opportunity to make personal connections with patients who needed them most,” said Jerry Warner, President, Americas and Global Commercial Functions, CooperVision. “At CooperVision, it has always been our mission to help improve the way people see each day, and we’re grateful to have had the ability to partner with eye care professionals to help those who have given so much of themselves to this fight.”

Through the program, CooperVision worked with eye care professionals to supply essential hospital workers with contact lenses—one box per eye, per patient—at no cost. The complimentary lenses included all 1-day, 2-week, and monthly brands from the company, such as clariti® 1 day, MyDay®, Biofinity®, Avaira® and Proclear® brands.*

As the impacts of the COVID-19 pandemic continue, CooperVision remains committed to supporting eye care professionals and their patients. For the latest updates on CooperVision’s efforts, visit

# # #


* CooperVision MiSight® 1 day was not included in the program

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit

Media Contact
Heather Kowalczyk, APR
McDougall Communications for CooperVision, Inc. or +1-585-434-2148